1. Accuray will host an analyst discussion on adaptive radiotherapy. 2. Event coincides with the ASTRO Annual Meeting in San Francisco. 3. Global leaders will discuss advancements in adaptive radiotherapy. 4. Analysts can gain insights on integration and practices in radiotherapy. 5. Event aims to enhance understanding of innovative treatment solutions.
The event's focus on innovations in adaptive radiotherapy showcases ARAY’s commitment to leadership, potentially attracting positive investor sentiment. Historical instances of similar events, like product launches at industry conferences, have led to stock upticks for medical device companies.
The focus on adaptive radiotherapy aligns with ARAY's core mission and innovations, which is vital for market position. As advancements in cancer treatment draw investment interest, engaging discussions may lead to enhanced stock performance.
Investor sentiment may shift rapidly due to new insights from the event, leading to immediate market reactions. Past events have shown that announcements at conferences often result in short-term price volatility.
Event Will Feature Global KOLs Sharing Their Perspectives on the Role of Adaptive Radiotherapy in Radiation Medicine
MADISON, Wis., Sept. 11, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ:ARAY) announced today that the company will host a discussion with analysts and investors on Monday, September 29, 2025, in conjunction with the American Society of Radiation Oncology (ASTRO) Annual Meeting in San Francisco, California. The event will take place in person at the ASTRO meeting and on a virtual platform, with presentations beginning at 1:30 pm PT (4:30 pm ET).
Analysts participating in the event will have a unique opportunity to hear first-hand from global thought leaders who will share their perspectives on the role of adaptive radiotherapy in radiation medicine. Topics include:
Both in-person and virtual guests must register in advance to participate in the Accuray meeting. Please RSVP here by September 25, 2025.
About Accuray
Accuray Incorporated (NASDAQ:ARAY) is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions that are designed to deliver radiation treatments for even the most complex cases – while making commonly treatable cases even easier – to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in Madison, Wisconsin, with facilities worldwide.
Investor Contact
Aman Patel, CFA
Investor Relations, ICR Healthcare
+1 (443) 450-4191
aman.patel@westwicke.com
Media Contact
Beth Kaplan
Public Relations Director, Accuray
bkaplan@accuray.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/accuray-to-host-analyst-event-at-the-american-society-of-radiation-oncology-meeting-on-september-29-2025-302554133.html
SOURCE Accuray Incorporated